Share Prices & Company Research

Stockbroking

Allergy Therapeutics

Current Price 11.25p Bid 10.50p Ask 11.50p Change -3.23%
Last Updated: 25/05/2020 19:57. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Financial Highlights Year Ended 30/06/2019

Revenue
£73.72m
Operating Profit/Loss
£4.39m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
25.50

Key Personnel

Mr Manuel Llobet
Chief Executive Officer
Mr Nicolas Wykeman
Finance Director
Mr Peter Jensen
Non-Executive Chairman
Dr Tunde Otulana
Non-Executive Director
Mr Scott Leinenweber
Non-Executive Director
Mr Stephen R Smith
Non-Executive Director
Ms Mary G Tavener
Non-Executive Director

Stock Details

EPIC
AGY
ISIN
GB00B02LCQ05
Shares in Issue
636.17m
Market cap
£71.57m

Analyst Views (2)

Strong Buy
 
100.00%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
11.25p
Bid Price
10.50p
Ask Price
11.50p
Volume
136,203
Change Today
-0.38p
% Change Today
-3.23%
Open
11.63p
Previous Close
11.25p
Intraday High
11.63p
Intraday Low
11.00p
52 Week High
15.50p
52 Week Low
7.38p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

News

Income Statement

Year End Date
30 Jun 2019
30 Jun 2018
 
£ (M)
£ (M)
Continuing Operations
Revenue
73.72
68.35
Operating Profit/Loss
4.39
-6.73
Net Interest
-0.10
-0.17
Pre-Tax Profit
4.29
-6.90
Profit After Tax from continuing operations
3.47
-7.53
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
3.47
-7.53
Attributable to:
Equity Holders of Parent Company
3.47
-7.53
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
30 Jun 2019
30 Jun 2018
Basic
0.55p
-1.27p
Diluted
0.52p
-1.27p
Adjusted
0.55p
-1.27p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
30 Jun 2019
30 Jun 2018
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
11.48
10.10
Intangible Assets
4.84
4.95
Investment Properties
n/a
n/a
Investments
5.55
5.04
Other Financial Assets
n/a
n/a
Other Non-Current Assets
n/a
n/a
Current Assets
Inventories
9.41
8.81
Trade & Other Receivables
9.78
6.59
Cash at Bank & In Hand
27.44
15.53
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
68.50
51.02

Liabilities

Year End Date
30 Jun 2019
30 Jun 2018
 
£ (M)
£ (M)
Current Liabilities
Borrowings
0.69
0.64
Other Current Liabilities
16.16
13.99
Total Current Liabilities
16.86
14.63
Non-Current Liabilities
Borrowings
1.74
2.41
Provisions
0.59
0.59
Other Non-Current Liabilities
11.75
10.35
Total Non-Current Liabilities
14.08
13.35
Other Liabilities
n/a
n/a
Total Liabilities
30.94
27.98

Net Assets

Year End Date
30 Jun 2019
30 Jun 2018
 
£ (M)
£ (M)
Net Assets
37.56
23.03

Capital & Reserves

Year End Date
30 Jun 2019
30 Jun 2018
 
£ (M)
£ (M)
Share Capital
0.65
0.61
Share Premium Account
112.58
102.42
Other Reserves
43.51
41.76
Retained Earnings
-119.18
-121.75
Shareholders Funds
37.56
23.03
Minority Interests/Other Equity
n/a
n/a
Total Equity
37.56
23.03

Dividend History

Dividend Metrics

Year End Date
30 Jun 2019
30 Jun 2018
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 22nd May 2020
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.